Melanoma
Latest News
Hydroquinone, found in skin-lightening agents worldwide, linked with increased skin cancer risk
“The magnitude of the risk was surprising,” one of the study authors said.
Conference Coverage
Consider the ‘long game’ in tumor management following Mohs surgery
“Tumors should be thought about in the context of the patient and not as a single or isolated cancer,” Dr. Keith L. Duffy said.
Latest News
Second opinions on melanocytic lesions swayed when first opinion is known
Downward and upward shifts in severity from an accurate diagnosis are concerning because of the likelihood they will lead to overtreatment or...
Feature
Getting cancer research on track again may require a ‘behemoth’ effort
Cancer Moonshot aims to cut cancer-related deaths in half, but funding and pandemic challenges may hinder progress.
Latest News
Experts: EPA should assess risk of sunscreens’ UV filters
The assessment is urgently needed and the results should be shared with the Food and Drug Administration, the experts said.
Latest News
FDA acts against sales of unapproved mole and skin tag products on Amazon, other sites
Warning letters sent to three companies address possible violations from selling unapproved drugs for mole and skin tag removal.
Latest News
Devices to detect skin cancer: FDA advisers offer mixed views
There's been a swell in recent years in the number of publications related to the use of AI and machine learning, which could give rise to new...
Latest News
Banana Boat recalls scalp sunscreen spray
The recall comes a little over a year after Johnson & Johnson recalled five sunscreens due to low levels of benzene.
Latest News
FDA panel urges caution with skin cancer–detecting tools
The FDA called a meeting amid growing interest in using technology to aid in finding cancers, with some of these products already marketed to...
Latest News
Amazon involved with new cancer vaccine clinical trial
The trial is aimed at finding “personalized vaccines” to treat breast cancer and melanoma, a form of skin cancer.
Conference Coverage
Pembrolizumab for melanoma bittersweet, doctor says
“Until we can further define who the highest-risk patients are, I think it’s hard to give it to everyone,” one doctor says.